Vaccines
Researchers from Cantonal Hospital in St. Gallen, Switzerland, have made a significant discovery about the efficacy of COVID-19 mRNA vaccines in patients with inflammatory bowel disease (IBD). According to a recent study published in the journal Vaccines, the vaccines induce robust systemic immune responses in IBD patients but fail to
Vaccines
The U.S. Department of Health and Human Services (HHS) has initiated a coordinated wind-down of its mRNA vaccine development efforts under the Biomedical Advanced Research and Development Authority (BARDA). This move involves canceling 22 mRNA vaccine development projects valued at nearly $500 million, as the current vaccines have proven
Vaccines
As students return to school in Georgia, medical experts and educators are concerned about the decline in childhood vaccination rates. Data show that Georgias kindergarten students are falling short of the threshold for herd immunity, with only 88.4% receiving the measles-mumps-rubella vaccine during the 2023-24 school year, compared to
Vaccines
President Bola Tinubu has congratulated the National Agency for Food and Drug Administration and Control (NAFDAC) on retaining the World Health Organisation's (WHO) Maturity Level 3 (ML3) status for the regulation of medicines and vaccines. This achievement is a result of NAFDAC's successful maintenance of a
COVID-19
Health experts are sounding the alarm as the US Health and Human Services Secretary, Robert F. Kennedy Jr., announces the cancellation of nearly $500 million in funding for mRNA vaccine development projects. The move follows a series of decisions by President Donald Trump's administration that appear to target
COVID-19
CureVac, a multinational biotech company, has resolved all pending patent litigation in the US related to mRNA-based COVID-19 vaccines with Pfizer and BioNTech. This resolution removes a significant overhang for CureVac, allowing the company to focus on its vaccine and treatment candidates. The agreement also includes a payment of $740
Social services
Brianna Wagner filed a petition for compensation under the National Vaccine Injury Compensation Program in October 2022, alleging a shoulder injury related to an influenza vaccine she received in November 2020. The parties stipulated that she suffered a vaccine-related injury, and on December 26, 2024, Chief Special Master Corcoran issued
Social services
Argentina's Deputy Minister of Health, Cecilia Loccisano, has traveled to the United States to advance joint work with the Department of Health and Human Services and the Pan American Health Organization (PAHO) on establishing new guidelines for health cooperation. The focus areas include regional production of medicines, vaccines,
Social services
GeoVax Labs, a clinical-stage biotechnology company, has issued a statement in response to the U.S. Department of Health and Human Services' (HHS) decision to terminate nearly $500 million in BARDA-funded mRNA vaccine development contracts. This action reflects a policy shift, underscored by HHS Secretary Kennedy's remarks
COVID-19
Researchers at Arizona State University have conducted a study to understand the reasons behind COVID-19 vaccine hesitancy among pregnant and lactating refugee women. The study, funded by Merck, found that participants expressed fear of long-term health effects, misinformation spread on social media, and the role of men in vaccine decision-making
COVID-19
The U.S. Department of Health and Human Services (HHS) has announced the beginning of a coordinated wind-down of its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA). This decision comes after a comprehensive review of mRNA-related investments initiated during the COVID-19 public health emergency.
Social services
The Biden administration is reportedly considering a drastic overhaul of the US Preventive Services Task Force, a panel of independent experts that guides preventive treatments and screenings for chronic diseases, mental health, and more. Health and Human Services Secretary Xavier Becerra's plan, if implemented, could result in the
